Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering

被引:60
作者
Myers, L
Takahashi, C
Mittler, RS
Rossi, RJ
Vella, AT
机构
[1] Univ Connecticut, Ctr Hlth, Div Immunol, Farmington, CT 06030 USA
[2] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA
[3] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30329 USA
[4] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30329 USA
关键词
D O I
10.1073/pnas.0837611100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To better understand how innate and adaptive immune responses interact with each other, we combined 4-1BB T cell costimulation with specific adjuvants to determine whether these treatments would influence specific T cell expansion and function in vivo. In the presence of 4-1BB ligation and Toll-like receptor 3 (TLR)3 and/or TLR4 triggering, CD8 T cell clonal expansion and survival was augmented profoundly. Specific T cells primed in vivo with TLR ligands responded normally to in vitro recall stimulus, but, surprisingly, copriming with 4-1BB costimulation significantly impaired the recall response even though many more specific effector T cells were rescued in vivo. Here, we demonstrate that the rescued CD8 T cells suppressed CD4 T cell proliferation via a type beta transforming growth factor-dependent mechanism. Thus, 4-1BB and TLR ligands induce survival of specific effector CD8 T cells with suppressive recall potential, which may explain the dual role that 4-1BB activation plays in mediating tumor clearance and prevention of autoimmune disease.
引用
收藏
页码:5348 / 5353
页数:6
相关论文
共 45 条
[1]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[2]   Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection [J].
Bertram, EM ;
Lau, P ;
Watts, TH .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :3777-3785
[3]   4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy [J].
Cannons, JL ;
Lau, P ;
Ghumman, B ;
DeBenedette, MA ;
Yagita, H ;
Okumura, K ;
Watts, TH .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1313-1324
[4]   TGF-β released by apoptotic T cells contributes to an immunosuppressive milieu [J].
Chen, WJ ;
Frank, ME ;
Jin, WW ;
Wahl, SM .
IMMUNITY, 2001, 14 (06) :715-725
[5]  
DASCH JR, 1989, J IMMUNOL, V142, P1536
[6]   Effects of TGF-β on the immune system:: implications for cancer immunotherapy [J].
de Visser, KE ;
Kast, WM .
LEUKEMIA, 1999, 13 (08) :1188-1199
[7]  
DESILVA DR, 1991, J IMMUNOL, V147, P3261
[8]   In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway [J].
Diehl, L ;
van Mierlo, GJD ;
den Boer, AT ;
van der Voort, E ;
Fransen, M ;
van Bostelen, L ;
Krimpenfort, P ;
Melief, CJM ;
Mittler, R ;
Toes, REM ;
Offringa, R .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :3755-3762
[9]  
DORF ME, 1984, ANNU REV IMMUNOL, V2, P127, DOI 10.1146/annurev.iy.02.040184.001015
[10]   I-J AS A RESTRICTION ELEMENT IN THE SUPPRESSOR T-CELL SYSTEM [J].
DORF, ME ;
BENACERRAF, B .
IMMUNOLOGICAL REVIEWS, 1985, 83 :23-40